WOODRIDGE, Ill., Oct. 10 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced that it will present at the BIO InvestorForum Conference. Advanced Life Sciences' management will provide an overview and update of the Company's business.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO )
The Company's presentation will be delivered at 2:30 PM Pacific Time on Thursday, October 19, 2006 at the Palace Hotel (Sea Cliff Room) in San Francisco, CA.
About Advanced Life Sciences
Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation. The Company's lead candidate, cethromycin, is a novel ketolide antibiotic in late-stage clinical development for the treatment of respiratory tract infections.
Visit us on the web at http://www.advancedlifesciences.com .
Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties include, among others, those relating to technology and product development, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in Advanced Life Sciences' filings with the Securities and Exchange Commission. Advanced Life Sciences undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGOPRN Photo Desk, photodesk@prnewswire.comAdvanced Life Sciences Holdings, Inc.CONTACT: Investor Relations Contact, Edward P. Flavin of Advanced LifeSciences Holdings, Inc., +1-630-739-6744 Ex 211
Web site: http://www.advancedlifesciences.com/
